These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31222179)

  • 1. Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.
    Lu LL; Smith MT; Yu KKQ; Luedemann C; Suscovich TJ; Grace PS; Cain A; Yu WH; McKitrick TR; Lauffenburger D; Cummings RD; Mayanja-Kizza H; Hawn TR; Boom WH; Stein CM; Fortune SM; Seshadri C; Alter G
    Nat Med; 2019 Jul; 25(7):1175. PubMed ID: 31222179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.
    Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F
    Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection.
    Amiano NO; Morelli MP; Pellegrini JM; Tateosian NL; Rolandelli A; Seery V; Castello FA; Gallego C; Armitano R; Stupka J; Erschen MA; Ciallella LM; de Casado GC; Cusmano L; Palmero DJ; Iovanna JL; García VE
    Sci Rep; 2020 May; 10(1):7472. PubMed ID: 32366931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.
    Mazurek GH; LoBue PA; Daley CL; Bernardo J; Lardizabal AA; Bishai WR; Iademarco MF; Rothel JS
    JAMA; 2001 Oct; 286(14):1740-7. PubMed ID: 11594899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the level of IFN-γ produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting.
    Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F
    Int Immunol; 2012 Feb; 24(2):71-8. PubMed ID: 22298884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
    Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
    EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Publisher Correction: m6A modification controls the innate immune response to infection by targeting type I interferons.
    Winkler R; Gillis E; Lasman L; Safra M; Geula S; Soyris C; Nachshon A; Tai-Schmiedel J; Friedman N; Le-Trilling VTK; Trilling M; Mandelboim M; Hanna JH; Schwartz S; Stern-Ginossar N
    Nat Immunol; 2019 Feb; 20(2):243. PubMed ID: 30635652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Publisher Correction: Cancer genetics, precision prevention and a call to action.
    Turnbull C; Sud A; Houlston RS
    Nat Genet; 2019 Jan; 51(1):196. PubMed ID: 30542102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy.
    Lighter-Fisher J; Surette AM
    Obstet Gynecol; 2012 Jun; 119(6):1088-95. PubMed ID: 22569120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.
    Nemes E; Rozot V; Geldenhuys H; Bilek N; Mabwe S; Abrahams D; Makhethe L; Erasmus M; Keyser A; Toefy A; Cloete Y; Ratangee F; Blauenfeldt T; Ruhwald M; Walzl G; Smith B; Loxton AG; Hanekom WA; Andrews JR; Lempicki MD; Ellis R; Ginsberg AM; Hatherill M; Scriba TJ;
    Am J Respir Crit Care Med; 2017 Sep; 196(5):638-648. PubMed ID: 28737960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term IFN-γ and IL-2 response for detection of latent tuberculosis infection in healthcare workers with discordant immunologic results.
    Sauzullo I; Mastroianni CM; Mengoni F; Ermocida A; Mascia C; Salotti A; Falciano M; Vullo V
    J Immunol Methods; 2014 Dec; 414():51-7. PubMed ID: 25111618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Hit
    Adankwah E; Lundtoft C; Güler A; Franken KLMC; Ottenhoff THM; Mayatepek E; Owusu-Dabo E; Phillips RO; Nausch N; Jacobsen M
    Front Immunol; 2019; 10():1518. PubMed ID: 31333654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.